Not Yet RecruitingPhase 3Phase 4ACTRN12608000088347

Post Amputation Phantom Limb Pain Study

Can Pregabalin prevent persistent post amputation pain?

Sponsor

John Hunter Hospital-Hunter Integrated Pain Service

Enrollment

120 participants

Start Date

Mar 1, 2008

Study Type

Interventional

Conditions

Persistent phantom limb pain post amputation

Summary

The aim of the study is to determine whether the use of the drug Pregabalin can reduce or eliminate phantom pain after leg amputations

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 0 N/As

Plain Language Summary

Simplified for easier understanding

This study investigates Post Amputation Phantom Limb Pain Study. It is looking for both men and women, aged 18 and older who have patient able to provide own informed consent. If you are interested, you may need to attend study visits and follow the research team's instructions.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

One month course of oral pregabalin commencing with a single preoperative 150md dose of pregabalin, followed by 75mg oral pregabalin BD for 7 days after surgery, then increasing to 75-150mg bd for the

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12608000088347